Regulating vaccines under the same liability regime as all other pharmaceuticals, and acknowledging problems as well as benefits associated with them, will likely lead to safer vaccines and a better informed public.
Continue reading How Democrats and Republicans can come together on vaccines
Why are America’s Tier 1A workers the most likely to refuse vaccination? Gallup, and numerous other surveys and reports, produce unexpected results.
Continue reading The biggest COVID-19 vaccine skeptics? Frontline health care workers
It would be foolhardy to base public policy decisions on the unrealistic prospect of a quick-fix vaccine.
Continue reading Don’t count on a coronavirus vaccine any time soon
The politicization of research funding is pervasive and paramount in decision-making.
Continue reading Medical research is too important to leave to the politicians
Governments have vast financial interests that skew their medical research.
Continue reading The EpiPen scandal is just a symptom of America’s unexplained allergy epidemic
A documentary on the mother of all medical controversies.
Continue reading Junk Science Week: Robert De Niro gets Vaxxed
Mumps outbreaks occur continually, most of them small and unreported. They’re attracting attention today only because NHL players are involved. And they’re certain to attract attention in future.
Continue reading Why doctors aren’t shocked that mumps have hit the NHL
Rolling back the government advantages given vaccines would level the R&D playing field and help end the drought in pharmaceutical breakthroughs.
Mistakes in novel areas of science inevitably happen, and especially in highly politicized periods where public panic can run high and governments are under the gun.
The medical-industrial-governmental complex spends more and more but has less and less to show for it.
Consumer Policy Institute 